(Date:11/20/2009)...DO recently announced that Dr. Dominique Hebrault ...ocess Analytical Technology (PAT) in Green Chemist...9. , (PRWEB) November 20,...l Technology (PAT) in Green Chemistry and Green En...al Technology (PAT) case studies will be presented...
(Date:11/19/2009)...Nov. 19 Spherix Incorpor...gy for diabetes therapy, and a provider of technic...plement, biotechnology and pharmaceutical companie...ed $6.3 million registered direct placement to ins...mmon stock and warrants to purchase up to 1,104,34...
(Date:11/19/2009)...re/ - Aegera Therapeutics Inc. announced today the... 2B study of AEG35156, a targeted antisense therap...gy indications. ,, The study, entitled "An Open...hibitor of Apoptosis (XIAP) Antisense AEG35156 Giv...arubicin in AML Following Failure of a Single Stan...
(Date:11/18/2009)...wswire/ -- Marrone Bio Innovations (MBI), a leader...on of effective and environmentally responsible pe... named an IC20 company by the Investors, Circle, t...l investing group. ,, Companies named to the IC...ts for all stakeholders, including investors, the ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2... States May Soon Follow, FREDERICK, Md., April 21... product reimbursement for ActiPatch(TM) for,kidne..., (Pink Sheets:,BIEL), is the maker of ActiPatch, ...which accelerates healing., Many commonly used ph...Advil, Motrin, Nuprin) and Naproxen (Aleve, Anapro...
...xchange Symbol: RVX, CALGARY, April 21 /PRNewswir... the "Company") (TSX:RVX) announced today that 948...ll automatically be extended,pursuant to the Compa...Staff Notice 2006-0001. The Company,s stock option...s would otherwise expire during a "blackout",tradi...
...AM, Mass., April 21 Thermo Fisher,Scientific Inc....e, announced,that it will present at the following...are Conference on Monday, May 5, 2008, at 4:00 ...MA., -- Bank of America Healthcare Conference on ...he Four Seasons Hotel, in Las Vegas, NV., -- Bair...
Other Biology Technology:Maryland Approves Medicaid Reimbursement for ActiPatch(R) 2Resverlogix Share Option Extension 2Thermo Fisher Scientific to Present at Upcoming Investor Conferences 2(Date:11/19/2009)...entists are revealing the genetic instructions ins... or maize, has one of the most complex sequences o...Madison genomicist David Schwartz, who was one of ...l Science . , "The maize genome is a true maze ... troubled would-be sequencers for years," says Sch...
(Date:11/19/2009)...genetic diversity in maize, also known as corn, re... a gene map that should pave the way to significan...f food, fuel, animal feed and fiber around the wor...own as a haplotype map, charts genetic diversity a...nes of maize. The research team, led by U.S. Depar...
(Date:11/19/2009)...e,s Ross Hardison, T. Ming Chu Professor of Bioche...ep toward unraveling how regulatory proteins contr...ent and growth. Working with collaborators includi...,s Hospital of Philadelphia, they focused specific... cells (erythrocytes). These cells contain large a...
Breaking Biology News(10 mins):Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Affymetrix Reports Second Quarter 2009 Results 52465 1Affymetrix Reports Second Quarter 2009 Results 52465 2Affymetrix Reports Second Quarter 2009 Results 52465 3Affymetrix Reports Second Quarter 2009 Results 52465 4Affymetrix Reports Second Quarter 2009 Results 52465 5Affymetrix Reports Second Quarter 2009 Results 52465 6Affymetrix Reports Second Quarter 2009 Results 52465 7Affymetrix Reports Second Quarter 2009 Results 52465 8Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 1Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 2Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 3Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 4Herley Industries Inc Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22 2009 Conference 52460 5Top Hepatitis C Treatments Equally Effective 52455 1Top Hepatitis C Treatments Equally Effective 52455 25X MEGAscript® T7 Kit from Ambion
RNAimage Kit from GenHunter
Mouse Anti-Rad 51C Monoclonal Antibody, Unconjugated, Clone 2H11/6 from ABR-Affinity BioReagents
...eptide derived from the C-terminal region of the h...-expressed growth factor spinal cord-derived growt...at by one amino acid replacement. Specificity: Re...roteins. Reactivity: Human (positive controls: NT...
Biology Products: